Health Care & Life Sciences » Pharmaceuticals | Aurobindo Pharma Ltd.

Aurobindo Pharma Ltd. | Mutual Funds

Mutual Funds that own Aurobindo Pharma Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
HDFC Growth Fund
8,570,828
1.46%
0
1.97%
07/31/2018
HDFC Premier Multi Cap Fund
6,761,000
1.14%
0
2.76%
07/31/2018
HDFC Equity Fund
6,247,526
1.07%
0
1.95%
07/31/2018
Birla Sun Life Frontline Equity Fund
5,490,981
0.94%
0
1.79%
07/31/2018
Vanguard Emerging Markets Stock Index Fund
4,310,977
0.74%
-32,410
0.05%
07/31/2018
Vanguard Total International Stock Index Fund
3,901,551
0.67%
210,919
0.01%
07/31/2018
HDFC Top 200 Fund
3,632,450
0.62%
0
1.61%
07/31/2018
Stichting Pensioenfonds ABP (Global Equity Portfolio)
3,454,659
0.59%
-2,015,300
0.01%
03/31/2018
Reliance Pharma Fund
2,850,000
0.49%
-100,000
7.75%
08/31/2018
Government Pension Fund - Global (The)
2,849,410
0.49%
1,438,762
0%
12/31/2017

About Aurobindo Pharma

View Profile
Address
Water Mark Building
Hyderabad TS 500084
India
Employees -
Website http://www.aurobindo.com
Updated 09/14/2018
Aurobindo Pharma Ltd. engages in the manufacture of generic pharmaceuticals and active pharmaceutical ingredients. It operates through the following geographical segments: India, USA, Europe, and Rest of the World. It portfolio includes antibiotics, anti-retrovirals, cardiovascular, central nervous system, gastroenterological, anti-allergies, and anti-diabetics.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.